Business ❯ Pharmaceutical Industry

Generic Drugs

Market Competition Market Access Market Dynamics Market Regulation Market Trends Market Impact Manufacturing Market Approval Drug Pricing Market Launches Biosimilars Market Launch International Trade Market Analysis Price Fixing Indian Pharmaceutical Companies Market Manipulation Market Supply Compounding Pharmacies Mifepristone Import Regulations Amneal Pharmaceuticals Supply Chain Management Manufacturing Standards Market Regulations Drug Development Licensing Agreements Exports Civica Rx CivicaRx Patent Expiry Market Introduction Patent Regulations Market Share Patent Litigation Drug Manufacturing Market Practices Investment Strategies Export Trade

Sandoz Agrees to $478.5 Million U.S. Settlement Over Generic Drug Pricing

The deal would resolve most state and reseller claims while leaving some opt-out suits and a 2027 trial as outstanding legal risks.

Trump Sets Phased Tariffs on Imported Generic Drugs

Glenmark Settles for $29.6 Million Over Alleged Generic Drug Price Conspiracy

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Supreme Court Skeptical of Expanding Inducement Liability in Skinny-Label Drug Case

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

India Cough Syrup Crisis: Sresan Pharma Owner Detained as Tamil Nadu Confirms Toxic Contamination

Deals Set $40 Generics of Twice-Yearly HIV Prevention Shot for 120 Countries by 2027